Here are relevant reports on : agile-development-market
-
DataOps Platform Market by Offering (Platform and Services), Type (Agile Development, DevOps, and Lean Manufacturing), Deployment Mode, Vertical (BFSI, Telecommunications, and Healthcare & Life Sciences) and Region - Global Forecast to 2028
The market for DataOps platform size is projected to reach USD 10.9 billion by 2028, at a CAGR of 23.0% during the forecast period. Major vendors in the global DataOps Platform market are Microsoft (US), IBM (US), Oracle (US), AWS (US), Informatica (US), Teradata (US), Wipro (India), Accenture (Ireland), SAS Institute (US), Hitachi Vantara (US), DataKitchen (US), Atlan (Singapore), Dataiku (US), Fosfor (India), Databricks (US), StreamSets (US), Talend (US), Collibra (US), Celonis (US), BMC Software (US), Saagie (France), Composable Analytics (US), Tengu.io (Belgium), Unravel Data (US), Monte Carlo Data (US), Census (US), RightData (US), Zaloni (US), Datafold (US), DataOps.live (UK), K2view (Israel).
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030
The global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Cloud-Based Application Development Services Market : Worldwide Market Forecast and Analysis (2014-2019)
Businesses around the world are facing stiff competition with numerous players rapidly joining their respective market space. . A business entity, therefore, needs to stay ahead of the competition as well as undergo changes in accordance with the changing market dynamics. It needs to build an intelligent operational framework in order to achieve sustainability. Companies are thus moving towards custom enterprise applications to improve business performance and meet unique business requirements. Enterprises are swiftly turning to cloud technologies for various operational changes since the past six to seven years. The major reasons behind the large scale demand for cloud-based enterprise applications have been the massive scalability and reduced operational costs offered by the cloud services. The scalability and extensible architectures offered by cloud-based applications support complete business availability for global customers, as it reduces development cycles and risks to a minimum. The major service types involved in the market are application consulting, customization, testing, integration, and other services such as training, support, and maintenance. The market revenues are considered from the total application development spending over private, public, and hybrid clouds. Security considerations in the public cloud differ substantially from that in a private cloud. This factor is considered to be a major constraint for the public cloud deployment segment during the forecast.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Preclinical Models In Drug Discovery & Development Market - 2019 By Types, Application & Geography
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Israel Biopharmaceutical Research and Development Market - Global Trends and Forecast to 2020
In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029
The global lipid nanoparticles market, valued at US$261.8 million in 2023, stood at US$271.8 million in 2024 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2029, culminating in a forecasted valuation of US$350.5 million by the end of the period. The growth of this market can be attributed to factors such as the development of lipid nanoparticle-based pharmaceuticals and the expanding application of lipid nanoparticles in anti-cancer and mRNA-based therapies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Real World Evidence Solutions Market by Component (Datasets (Claims, Clinical, Pharmacy, Genomics), Application (Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement), End User (Pharma, Medtech, Payers, Provider), Region - Global Forecast to 2030
The global real world evidence solutions market, valued at US$4.74 billion in 2024, stood at US$5.42 billion in 2025 and is projected to advance at a resilient CAGR of 14.8% from 2025 to 2030, culminating in a forecasted valuation of US$10.8 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Asia Pacific Digital Twin Market by Application (Product Design & Development, Performance Monitoring, Predictive Maintenance, Inventory Management, Business Optimization), Industry (Automotive & Transportation, Infrastructure) - Forecast to 2030
The Asia Pacific digital twin market is expected to be valued at USD 4.57 billion in 2025 and USD 32.57 billion by 2030, registering a CAGR of 48.1% during the forecast period. The Key Players include market Fresenius SE & Co. KGaA (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Danone S.A. (France), B. Braun Melsungen AG. (US), Nestlé S.A. (Switzerland), , Boston Scientific Corporation (US), Becton, Dickinson and Company (US), CONMED Corporation (US), Baxter International Inc. (US), Abbott (US), Moog, Inc. (US), Cook Medical (US), Terumo Corporation (Japan), Weigao Medical International Co., Ltd. (China), JMS Co., Ltd. (Japan), Vygon (France), Applied Medical Technology (US), Amsino International Inc. (US), and Medela AG (Switzerland).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030
Global high content screening market valued at $1.47B in 2024, reached $1.52B in 2025, and is projected to grow at a robust 7.5% CAGR, hitting $2.19B by 2030. Market growth in the Asia Pacific can be attributed to the increased pharmaceutical and biotechnology investments and the rising demand for personalized medicine.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
